Lipid Profiles are Altered in Rats Fed with Different Garlic Cultivars

ORIGINAL ARTICLE
Ester Yoshie Yosino da Silva¹, Celso Luiz Moretti², Leonora Mansur Mattos²*

¹College of Health Sciences, University of Brasilia, Brasilia, DF, Brazil; ²Embrapa, Parque Estação Biológica, Brasilia, DF, Brazil

*Corresponding author: Leonora Mansur Mattos. Embrapa, Parque Estação Biológica, s/n, 70770-901, Brasilia, DF, Brazil. Email: leonora.mattos@embrapa.br

Published: September 12, 2015. DOI: 10.21103/Article5(3)_OA9

Abstract: 

Garlic has antioxidant and hypocholesterolemic properties that are attributed to its organosulfur compounds being allicin, which is reported to be the most active of these  compounds. We hypothesized that allicin content could reduce plasma concentrations of triglycerides (TG), total cholesterol (TC), HDL (high density lipoproteins), VLDL (very low density lipoproteins), and glucose. Two different cultivars of commercial garlic, Peruano and Jinxiang, were used. Thirty male Wistar rats were distributed into 6 groups and fed for 15 days with standard diet (Control), Control with Peruano garlic treatment (CGP), Control with Jinxiang garlic treatment (CGCH), cholesterol-added control diet (CholC), cholesterol-added diet with Peruano garlic treatment (CholGP), and cholesterol-added diet with Jinxiang garlic treatment (CholGCH). Garlic treatment consisted of a daily oral dose of 1ml of lyophilized garlic. We observed that garlic treatment in Control group significantly reduced plasma TG and VLDL concentrations. The CGCH group presented a significant increase in plasma TC levels (25.5%) and glucose (11%). No significant changes in TC, HDL, TG and VLDL were observed in CholGP and CholGCH, but levels of fasting plasma glucose were increased: CholGP (23%) and CholGCH (27.5%). Results suggested allicin treatments alter lipid profile in rats. Nevertheless, further studies are necessary to address the increase in plasma glucose levels.

Keywords: 
powder garlic; allicin; rats; cholesterol; triglycerides; fasting plasma glucose.
References: 
  1. Omar SH, Al-Wabel NA. Organosulfur compounds and possible mechanism of garlic in cancer. Saudi Pharm J. 2010; 18(1):51-58.
  2. Agarwall KC. Therapeutic actions of garlic constituents. Med Res Rev. 1996; 16(1):111-24.
  3. Khatua TN, Adela R, Banerjee SK. Garlic and cardioprotection: insights into the molecular mechanisms 1. Can J Physiol Pharm. 2013; 91(6): 448-58.
  4. Bayan L, Koulivand PH, Gorji A. Garlic: a review of potential therapeutic effects. Avicenna J Phytomed. 2014; 4(1):1-14.
  5. Fei ML, Tong LI, Wei LI, De Yang L. Changes in antioxidant capacity, levels of soluble sugar, total polyphenol, organosulfur compound and constituents in garlic clove during storage. Ind Crop Prod. 2015; 69:137-42.
  6. Borlinghaus J, Albrecht F, Gruhlke MC, Nwachukwu ID, Slusarenko AJ. Allicin: Chemistry and biological properties. Molecules. 2014; 19(8):12591-618.
  7. Iciek M, Kwiecień I, Chwatko G, Sokołowska‐Jeżewicz M, Kowalczyk‐Pachel D,  Rokita H. The effects of garlic‐derived sulfur compounds on cell proliferation, caspase 3 activity, thiol levels and anaerobic sulfur metabolism in human hepatoblastoma HepG2 cells. Cell Biochem Funct. 2012; 30(3):198-04.
  8. Kay HY, Yang JW, Kim TH, Kang B, Ryu JH, Jeon R, et al. Ajoene, a stable garlic by-product, has an antioxidant effect through Nrf2-mediated glutamate-cysteine ligase induction in HepG2 cells and primary hepatocytes. J Nutr. 2010; 140(7):1211-19.
  9. Sohn CW, Kim H, You BR, Kim MJ, Kim HJ, Lee JY, et al. High temperature-and high pressure-processed garlic improves lipid profiles in rats fed high cholesterol diets. Journal of Medicinal Food. 2012; 15(5):435-40.
  10. Chen K, Keaney Jr JF. Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease. Curr Atheroscler Rep. 2012; 14(5):476-83.
  11. Rahman K, Lowe GM. Garlic and cardiovascular disease: a critical review. J Nutr. 2006; 136(3): 736S-40S.
  12. Ried K, Toben C, Fakler P.). Effect of garlic on serum lipids: an updated meta-analysis. Nutr Res. 2013; 71(5): 282-99.
  13. Yun HM, Ban JO, Park KR, Lee CK, Jeong HS, Han SB, et al. Potential therapeutic effects of functionally active compounds isolated from garlic. Pharmacol Therapeut. 2014; 142(2): 183-95.
  14. Zeng T, Zhang CL, Song FY, Zhao XL, Xie KQ. Garlic oil alleviated ethanol-induced fat accumulation via modulation of SREBP-1, PPAR-α, and CYP2E1. Food Chem Toxicol. 2012; 50(3): 485-91.
  15. Heidarian E, Jafari-Dehkordi E, Seidkhani-Nahal A. Effect of garlic on liver phosphatidate phosphohydrolase and plasma lipid levels in hyperlipidemic rats. Food Chem Toxicol. 2011; 49(5): 1110-14.
  16. Tsai CW, Chen HW, Sheen LY, Lii CK. Garlic: Health benefits and actions. BioMedicine. 2012; 2(1): 17-29.
  17. Koseoglu M, Isleten F, Atay A, Kaplan YC. (2010). Effects of acute and subacute garlic supplement administration on serum total antioxidant capacity and lipid parameters in healthy volunteers. Phytother Res. 2010:24(3): 374-78.
  18. Sobenin IA, Pryanishnikov VV, Kunnova LM, Rabinovich YA, Martirosyan DM,  Orekhov AN. The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease. Lipids Health Dis. 2010; 9: 119.
  19. INA (2005). Allicin Content in Garlic by HPLC (INA method 110.001). NSF International. Allicin by high-performance liquid chromatography. (INA Method 110.001). Retrieved from http://www.nsf.org/business/ina/garlic.asp.
  20. Lawson LD, Wang ZJ. Low allicin release from garlic supplements: a major problem due to the sensitivities of alliinase activity. J Agr Food Chem. 2001; 49(5): 2592-99.  
  21. Yanagita T, Han SY, Wang YM, Tsuruta Y, Anno T. Cycloalliin, a cyclic sulfur imino acid, reduces serum triacylglycerol in rats. Nutrition. 2003;19(2): 140-143.
  22. Gorinstein S, Jastrzebski Z, Namiesnik J, Leontowicz H, Leontowicz M, Trakhtenberg S. The atherosclerotic heart disease and protecting properties of garlic: contemporary data. Mol Nutr Food Res. 2007; 51(11): 1365-81.
  23. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem.1972; 18(6):499-02.
  24. Elkayam A, Peleg E, Grossman E, Shabtay Z, Sharabi Y. (2013). Effects of allicin on cardiovascular risk factors in spontaneously hypertensive rats. Isr Med Assoc J. 2013; 15(3):170-3.
  25. Lee S, Joo H, Kim CT, Kim IH, Kim Y. High hydrostatic pressure extract of garlic increases the HDL cholesterol level via up-regulation of apolipoprotein AI gene expression in rats fed a high-fat diet. Lipids Health Dis. 2012; 11(77):1-7.
  26.  Daniels JB. Lose weight in record time with the fast metabolism diet: how certain foods can help you to shed those extra pounds. Speedy Publishing LLC; 2013.
  27. Bloem E, Schroetter S, El-Khayat ASM, Schnug E. Influence of sulphur and nitrogen supply on the pigment content of oilseed rape, marigold, and beetroot. Phyton. 2011; 50(2):301-17.
  28. Lee J, Gupta S, Huang JS, Jayathilaka LP, Lee BS. HPLC–MTT assay: Anticancer activity of aqueous garlic extract is from allicin. Anal Biochem. 2013; 436(2):187-9.
  29. Lawson LD, Hughes BG. Characterization of the formation of allicin and other thiosulfinates from garlic. Planta Med.1992; 58(4):345-50.
  30. Calín-Sánchez Á, Figiel A, Wojdyło A, Szarycz M, Carbonell-Barrachina ÁA. Drying of garlic slices using convective pre-drying and vacuum-microwave finishing drying: kinetics, energy consumption, and quality studies. Food Bioprocess Tech. 2014; 7(2):398-408.
  31. Lawson LD, Wang ZYJ, Hughes BG. γ-Glutamyl-S-alkylcysteines in garlic and other Allium spp.: Precursors of age-dependent trans-1-propenyl thiosulfinates. J Nat Prod. 1991; 54(2):436-44.
  32. Cavagnaro PF, Galmarini CR. Effect of processing and cooking conditions on onion (Allium cepa L.) induced antiplatelet activity and thiosulfinate content. J Agr Food Chem. 2012; 60(35):8731-37.
  33. Chen S, Shen X, Cheng S, Li P, Du J, Chang Y, et al. Evaluation of garlic cultivars for polyphenolic content and antioxidant properties. PloS One. 2013; 8(11):e79730.
  34. Nazari B. Comparison of the Effect of Different Levels of Garlic Powder on the Levels of Serum Cholesterol and Triglyceride of Two Strains Broiler Chicks (Arian and Ross). Qom University of Medical Sciences Journal. 2012; 2(3).
  35. Chi MS, Koh ET, Stewart TJ. (1982). Effects of garlic on lipid metabolism in rats fed cholesterol or lard. J Nutr. 1982; 112(2): 241-8.
  36. Asdaq SMB. Antioxidant and Hypolipidemic Potential of Aged Garlic Extract and Its Constituent, S-Allyl Cysteine, in Rats. J Evid Based Complementary Altern Med. 2015; 1:1-7.
  37. Aouadi R, Aouidet A, Elkadhi A, Rayana MCB, Jaafoura H, Tritar B, et al. Effect of fresh garlic (Allium sativum) on lipid metabolism in male rats. Nutr Res. 2000; 20(2):273-80.
  38. Ali M, Al-Qattan KK, Al-Enezi F, Khanafer RMA, Mustafa T. Effect of allicin from garlic powder on serum lipids and blood pressure in rats fed with a high cholesterol diet. Prostag Leukotr Ess. 2000; 62(4):253-259.
  39. Santhosha SG, Jamuna P, Prabhavathi SN. Bioactive components of garlic and their physiological role in health maintenance: A review. Food Bioscience. 2013; 3:59-74.
  40. Thomson M, Al-Qattan KK, Bordia T, Ali M. Including garlic in the diet may help lower blood glucose, cholesterol, and triglycerides. J Nutr. 2006; 136(3):800S-02S.
  41. Jung ES, Park SH, Choi EK, Ryu BH, Park BH, Kim DS, et al. Reduction of blood lipid parameters by a 12-week supplementation of aged black garlic: a randomized controlled trial. Nutrition. 2014; 30(9):1034-1039.
  42. Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Borén J, Catapano AL, et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J. 2011; 32(11):1345-61.
  43. Seo YJ, Gweon OC, Im J, Lee YM, Kang MJ, Kim JI. Effect of garlic and aged black garlic on hyperglycemia and dyslipidemia in animal model of type 2 diabetes mellitus. Journal of Food Science and Nutrition. 2009;14(1):1-7.
  44. Eilat-Adar S, Sinai T, Yosefy C,  Henkin Y. Nutritional recommendations for cardiovascular disease prevention. Nutrients. 2013; 5(9):3646-3683.
  45. USFDA (2002). Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers. Center for Drug Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services.

The fully formatted PDF version is available.           

Download Article

Int  J Biomed. 2015; 5(3):155-161. © 2015 International Medical Research and Development Corporation. All rights reserved.